Rubicon Research Ltd, a speciality pharmaceutical company, is gearing up to launch its Initial Public Offering (IPO). The company has fixed the price band at ₹461 to ₹485 per equity share, valuing it at around ₹7,500–₹8,000 crore.
The IPO will open for subscription on October 9, 2025, and close on October 13, 2025. The total issue size stands at ₹1,085 crore, comprising both a fresh issue and an Offer for Sale (OFS).
Rubicon Research IPO Details
| Particulars | Details |
|---|---|
| IPO Open Date | October 9, 2025 |
| IPO Close Date | October 13, 2025 |
| Price Band | ₹461 – ₹485 per share |
| Face Value | ₹10 per share |
| Issue Size | ₹1,085 crore |
| Fresh Issue | ₹500 crore |
| Offer for Sale (OFS) | ₹585 crore |
| Lot Size | 30 Shares |
| Listing on | NSE, BSE |
| Lead Managers | Kotak Mahindra Capital, Axis Capital, ICICI Securities |
About Rubicon Research
Rubicon Research Ltd is a global, innovation-driven pharmaceutical company focusing on complex generics and speciality formulations.
Established in 2000, Rubicon operates US FDA-approved facilities in India and Canada, exporting products to the US, Europe, and other regulated markets. The company’s business model revolves around research-led drug development, licensing, and manufacturing.
IPO Objectives Of About Rubicon Research
The company intends to use the proceeds from the fresh issue for:
- Debt repayment and reduction
- Funding strategic acquisitions and expansions
- General corporate purposes
The Offer for Sale portion will allow existing investors, including General Atlantic Singapore RR Pte. Ltd., to partially offload their stake.
Also Read: Canara HSBC Life Insurance IPO – Check Key Details
Pre-IPO Placement
Ahead of the IPO, Rubicon Research raised ₹250 crore from Amansa Investments through a pre-IPO placement at ₹484.47 per share. This early investment indicates strong institutional confidence in Rubicon’s growth potential.
Financial Highlights Of About Rubicon Research
- Revenue Growth: 3× over the last three financial years
- EBITDA Growth: 6× increase during the same period
- R&D Spend: 10.4% of revenue in FY26 Q1
- Global Presence: Products sold in 30+ countries
Important Rubicon Research IPO Dates
| Event | Date |
|---|---|
| IPO Open | October 9, 2025 |
| IPO Close | October 13, 2025 |
| Basis of Allotment | October 16, 2025 |
| Refunds Initiation | October 17, 2025 |
| Shares Credit to Demat | October 20, 2025 |
| Listing Date | October 21, 2025 |
Rubicon Research IPO FAQs
Q1. What is the Rubicon Research IPO price band?
The IPO price band is ₹461 to ₹485 per share.
Q2. When will Rubicon Research IPO open and close?
The IPO opens on October 9, 2025, and closes on October 13, 2025.
Q3. What is the lot size for the Rubicon Research IPO?
The lot size is 30 shares, meaning investors must apply for a minimum of 30 shares and in multiples thereof.
Q4. What is the total issue size of the IPO?
The total issue size is ₹1,085 crore, including fresh issue and OFS.
Q5. When is the Rubicon Research IPO listing date?
The shares are expected to list on October 21, 2025, on both NSE and BSE.
